leisure time -WSS

leisure time

author：hotspot 2025-09-27 16:49:37 - browse：1481

Matts Take Column Illustration — Molly Ferguson for STAT

What do you say to a patient when the FDA rejects “their” experimental drug — one that they believe can alleviate at least some of their suffering?

That question arises in the aftermath of a dramatic moment at the Food and Drug Administration last week. Over the FDA’s protests, a small biotechnology company called BrainStorm Cell Therapeutics had insisted that the agency evaluate its experimental treatment for amyotrophic lateral sclerosis, or ALS, brand named NurOwn. ALS patients made fervent pleas for the medicine, a type of stem cell preparation, based on reports on social media and re-analyses of the data that they thought indicated it might be of some help to those with the fatal disease.

But the FDA methodically dismantled BrainStorm’s application. The medicine couldn’t work the way the company said it would, the agency insisted; the clinical trials didn’t show it was effective; and it was not clear BrainStorm could manufacture the medicine with sufficient quality. Worst of all, more patients died among those who received the drug than those who got placebo. The FDA’s panel of expert advisers voted 17 to 1 that the medicine was not safe and effective, with one person abstaining. The agency doesn’t have to follow the panel’s advice but probably will.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： 2023 Nobel Prize in Medicine goes to Karikó and Weissman

WSS

RSV injection headlines need to be accurate for good uptake

Disclosing genetic information: not as worrisome as once feared

Congress extends some pandemic preparedness programs

Study points to new risk in gene therapy death of Terry Horgan

Cloning humans is technically possible. It's curious no one has tried

The United States is paying nearly triple for new Covid vaccines

explore

leisure time

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

WATCH: Why do fingernails fall off when they're damaged?

Wildfire smoke exposes gaps in outdoor worker protections

Stop Congress from blocking public access to science

Medicare proposal to cover medical devices draws a mixed reaction

2023 Nobel Prize in Medicine goes to Karikó and Weissman

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Malaria cases in Florida and Texas: Here’s what you need to know

Setback for rare diseases as Taysha Gene Therapies pulls back

hotspot

Health insurers' Q3 question: how much care are people getting?

The battle over the Brookhaven Landfill on Long Island

The science behind Janet Jackson's pregnancy at 49

RSV injection headlines need to be accurate for good uptake

The science behind Janet Jackson's pregnancy at 49

Some top drug companies are starting to take action on climate

Wikipedia

knowledge

explore

explore